No, erosive gastritis is NOT equivalent to a gastric ulcer
Erosive gastritis and gastric ulcers are distinct pathological entities that differ fundamentally in their depth of mucosal injury, clinical significance, and management implications.
Key Distinctions
Depth of Mucosal Injury
The critical difference lies in the extent of tissue damage:
Erosive gastritis: Involves superficial mucosal breaks that do not penetrate through the muscularis mucosae. These are shallow lesions affecting only the surface epithelium 1, 2.
Gastric ulcers: Represent deeper, circumscribed mucosal breaks that extend through the muscularis mucosae into the submucosa or deeper layers, with a defined diameter (traditionally ≥5mm with perceptible depth, though FDA criteria use ≥3mm) 1.
Clinical Significance and Natural History
The distinction has important prognostic implications:
Erosions are typically acute, transient lesions that "come and go rapidly and have no known correlation to chronic ulcers or clinical events" 1. They heal quickly without scarring.
Gastric ulcers are chronic lesions with significant risk of complications including bleeding, perforation, and stricture formation 3. They require more aggressive and prolonged treatment 4.
Histopathological Differences
The inflammatory patterns differ substantially 2:
Erosive gastritis: Characterized by predominance of plasma cells with few polymorphonuclear leukocytes, often with regenerative glandular hyperplasia
Peptic ulcer disease: Shows different inflammatory infiltrate patterns typical of deeper tissue injury
Treatment Implications
While both conditions may respond to acid suppression, the management intensity differs:
Erosive gastritis: May respond to standard antacid treatment, though the underlying nodular changes often persist even after erosion healing 2. Does not typically require the intensive, prolonged PPI therapy mandated for ulcers.
Gastric ulcers: Require definitive ulcer healing therapy with PPIs, H. pylori eradication when present, and mandatory follow-up endoscopy at 6 weeks to confirm healing and exclude malignancy 5. Secondary prevention strategies are essential 6.
Common Clinical Pitfall
The most important caveat: Endoscopists may have difficulty distinguishing NSAID-induced discrete acute erosions from clinically significant ulcers 1. This has led to over-diagnosis of "ulcers" in clinical trials. When evaluating endoscopy reports, confirm whether lesions meet true ulcer criteria (depth and size) rather than representing superficial erosions.
Association vs. Equivalence
While erosive gastritis can coexist with peptic ulcer disease 7, 8 and shares some risk factors (H. pylori infection, NSAIDs), this association does not make them equivalent conditions. Erosive gastritis may share characteristics of the "duodenal ulcer phenotype" with antral-predominant gastritis 9, but remains a distinct entity.